The afternoon session began with from Zurich student Ishani Banik (SWISS2) who presented her ongoing work using zebrafish melanoma models to perform in vivo screening of functional
novel oncogenic driver mutations.
Having realized my passion for the same and determined about improvising medical treatment for melanoma cancer I am now working on «Functional in vivo screening of
novel oncogenic driver mutations in a zebrafish melanoma model» under the guidance of Prof. Levesque Mitchell Paul.
Project Title: Functional in vivo screening of
novel oncogenic driver mutations in a zebra fish melanoma model
Not exact matches
Notably, MYH9, PPP1R12B and TP53BP2 were also frequently aberrated in human ILC, highlighting these genes as
drivers of a
novel oncogenic pathway underlying ILC development.